Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products. Its OVP segment includes private label vaccine and pharmaceutical production for cattle but also for other species, including equine, porcine, avian, feline and canine. All OVP products are sold by third parties under third-party labels. It focuses on supporting veterinarians in canine and feline healthcare space. It offers a line of veterinary blood testing and other instruments. It manufactures biological and pharmaceutical products for other animal health companies.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Laboratories & Research
- Sub-Industry: N/A
- Symbol: NASDAQ:HSKA
- CUSIP: N/A
- Web: www.heska.com
Capitalization:- Market Cap: $697.15 million
- Outstanding Shares: 7,116,000
Average Prices:- 50 Day Moving Avg: $99.80
- 200 Day Moving Avg: $84.62
- 52 Week Range: $32.26 - $110.25
P/E:- Trailing P/E Ratio: 52.47
- Foreward P/E Ratio: 47.56
- P/E Growth: 2.96
Sales & Book Value:- Annual Revenue: $133.32 million
- Price / Sales: 5.23
- Book Value: $13.07 per share
- Price / Book: 7.50
Profitability:- EBIDTA: $21.99 million
- Net Margins: 7.55%
- Return on Equity: 10.46%
- Return on Assets: 7.84%
Debt:- Current Ratio: 2.76%
- Quick Ratio: 1.62%
Misc:- Average Volume: 119,184 shs.
- Beta: 0.83
- Short Ratio: 0.85
Frequently Asked Questions for Heska Corp (NASDAQ:HSKA)
What is Heska Corp's stock symbol?
Heska Corp trades on the NASDAQ under the ticker symbol "HSKA."
How were Heska Corp's earnings last quarter?
Heska Corp (NASDAQ:HSKA) released its quarterly earnings results on Tuesday, May, 2nd. The company reported $0.61 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.24 by $0.37. The business had revenue of $30.38 million for the quarter, compared to the consensus estimate of $33.31 million. Heska Corp had a net margin of 7.55% and a return on equity of 10.46%. The firm's revenue was up 11.9% compared to the same quarter last year. View Heska Corp's Earnings History.
Where is Heska Corp's stock going? Where will Heska Corp's stock price be in 2017?
5 analysts have issued 12-month price objectives for Heska Corp's stock. Their predictions range from $71.00 to $106.00. On average, they expect Heska Corp's stock price to reach $87.33 in the next year. View Analyst Ratings for Heska Corp.
Who are some of Heska Corp's key competitors?
Some companies that are related to Heska Corp include Abaxis (ABAX), Genomic Health (GHDX), Analogic (ALOG), BioTelemetry (BEAT), China Cord Blood Corp (CO), NeoGenomics (NEO), Natera (NTRA), Novadaq Technologies (NVDQ), Enzo Biochem (ENZ), InVitae Corp (NVTA), RadNet (RDNT), Alliance HealthCare Services (AIQ), Fluidigm (FLDM), Miragen Therapeutics (MGEN), Cytosorbents Corp (CTSO), VolitionRX Ltd (VNRX), Cancer Genetics (CGIX) and Biocept (BIOC).
Who owns Heska Corp stock?
Heska Corp's stock is owned by a number of of institutional and retail investors. Top institutional investors include Neuberger Berman Group LLC (6.31%), Vanguard Group Inc. (4.97%), Credit Suisse AG (4.48%), Riverbridge Partners LLC (3.46%), Bank of New York Mellon Corp (2.87%) and Russell Investments Group Ltd. (2.71%). Company insiders that own Heska Corp stock include Carol Wrenn, G Irwin Gordon, Jason A Napolitano, John Mcmahon, Kevin S Wilson, Michael J Mcginley, Nancy Wisnewski, Robert B Grieve, Rod Lippincott, Sharon J Larson, Sharon L Riley and Steve Asakowicz. View Institutional Ownership Trends for Heska Corp.
Who sold Heska Corp stock? Who is selling Heska Corp stock?
Heska Corp's stock was sold by a variety of institutional investors in the last quarter, including Park West Asset Management LLC, Wells Fargo & Company MN, Morgan Stanley, Summit Creek Advisors LLC, Thrivent Financial For Lutherans, Cortina Asset Management LLC, Grace & White Inc. NY and EAM Investors LLC. Company insiders that have sold Heska Corp stock in the last year include Carol Wrenn, G Irwin Gordon, Jason A Napolitano, John Mcmahon, Kevin S Wilson, Nancy Wisnewski, Rod Lippincott and Steve Asakowicz. View Insider Buying and Selling for Heska Corp.
Who bought Heska Corp stock? Who is buying Heska Corp stock?
Heska Corp's stock was purchased by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Neuberger Berman Group LLC, Vanguard Group Inc., Dimensional Fund Advisors LP, Principal Financial Group Inc., Bank of New York Mellon Corp, Acadian Asset Management LLC and Nicholas Investment Partners LP. Company insiders that have bought Heska Corp stock in the last two years include Sharon J Larson and Sharon L Riley. View Insider Buying and Selling for Heska Corp.
How do I buy Heska Corp stock?
Shares of Heska Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Heska Corp stock cost?
One share of Heska Corp stock can currently be purchased for approximately $97.97.
Earnings History for Heska Corp (NASDAQ:HSKA)Earnings History by Quarter for Heska Corp (NASDAQ:HSKA)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/2/2017 | Q1 2017 | $0.24 | $0.61 | $33.31 million | $30.38 million | View | Listen |  |
| 2/28/2017 | Q416 | $0.37 | $0.46 | $34.56 million | $39.50 million | View | Listen | |
| 11/1/2016 | Q316 | $0.26 | $0.45 | $31.36 million | $33.40 million | View | N/A | |
| 8/3/2016 | Q216 | $0.18 | $0.35 | $28.47 million | $30.00 million | View | N/A | |
| 5/3/2016 | Q116 | ($0.02) | $0.17 | $23.32 million | $27.10 million | View | N/A | |
| 3/3/2016 | Q415 | $0.17 | $0.28 | $28.31 million | $29.80 million | View | N/A | |
| 11/11/2015 | Q315 | $0.08 | $0.20 | $24.31 million | $28.00 million | View | Listen | |
| 7/29/2015 | Q215 | $0.10 | $0.17 | $24.11 million | $23.90 million | View | Listen | |
| 5/7/2015 | Q115 | $0.09 | $0.09 | $23.97 million | $22.90 million | View | N/A | |
| 3/5/2015 | Q414 | $0.15 | $0.12 | $24.20 million | $24.30 million | View | N/A | |
| 10/29/2014 | Q3 2014 | ($0.01) | $0.08 | $19.39 million | $21.81 million | View | N/A | |
| 7/30/2014 | Q2 | ($0.03) | $0.17 | $19.78 million | $22.92 million | View | N/A | |
| 5/8/2014 | Q1 2014 | ($0.01) | $0.03 | $20.31 million | $20.79 million | View | N/A | |
| 3/27/2014 | | $0.04 | $0.20 | | | View | N/A | |
| 8/7/2013 | Q2 2013 | ($0.01) | ($0.38) | $19.85 million | $18.30 million | View | N/A | |
| 11/13/2012 | Q312 | $0.08 | ($0.01) | $19.70 million | $16.90 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Heska Corp (NASDAQ:HSKA)2017 EPS Consensus Estimate: $1.67
2018 EPS Consensus Estimate: $2.04
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $0.20 | $0.23 | $0.22 |
| Q2 2017 | 2 | $0.36 | $0.36 | $0.36 |
| Q3 2017 | 2 | $0.46 | $0.51 | $0.49 |
| Q4 2017 | 2 | $0.61 | $0.61 | $0.61 |
| Q1 2018 | 1 | $0.30 | $0.30 | $0.30 |
| Q2 2018 | 1 | $0.45 | $0.45 | $0.45 |
| Q3 2018 | 1 | $0.56 | $0.56 | $0.56 |
| Q4 2018 | 1 | $0.73 | $0.73 | $0.73 |
(Data provided by Zacks Investment Research)
Dividend History for Heska Corp (NASDAQ:HSKA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Heska Corp (NASDAQ:HSKA)Insider Ownership Percentage: 15.30%
Institutional Ownership Percentage: 77.40%
Insider Trades by Quarter for Heska Corp (NASDAQ:HSKA)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 5/24/2017 | Nancy Wisnewski | EVP | Sell | 250 | $100.17 | $25,042.50 | |
| 5/23/2017 | Carol Wrenn | Director | Sell | 1,630 | $96.95 | $158,028.50 | |
| 5/23/2017 | John Mcmahon | CFO | Sell | 587 | $97.00 | $56,939.00 | |
| 5/4/2017 | Sharon J Larson | Director | Buy | 1,000 | $90.00 | $90,000.00 | |
| 4/11/2017 | Jason A. Napolitano | COO | Sell | 1,100 | $102.98 | $113,278.00 | |
| 4/10/2017 | Jason A. Napolitano | COO | Sell | 3,900 | $102.94 | $401,466.00 | |
| 3/9/2017 | John Mcmahon | CFO | Sell | 708 | $97.42 | $68,973.36 | |
| 3/9/2017 | Rod Lippincott | EVP | Sell | 5,157 | $97.87 | $504,715.59 | |
| 3/6/2017 | Kevin S Wilson | CEO | Sell | 8,000 | $90.00 | $720,000.00 | |
| 1/10/2017 | Jason A. Napolitano | COO | Sell | 5,000 | $74.73 | $373,650.00 | |
| 11/29/2016 | G Irwin Gordon | Director | Sell | 3,000 | $66.11 | $198,330.00 | |
| 11/28/2016 | John Mcmahon | CFO | Sell | 1,999 | $65.64 | $131,214.36 | |
| 11/22/2016 | Rod Lippincott | EVP | Sell | 5,000 | $64.85 | $324,250.00 | |
| 9/1/2016 | Jason A. Napolitano | CFO | Sell | 5,000 | $52.53 | $262,650.00 | |
| 8/29/2016 | Kevin S Wilson | CEO | Sell | 20,000 | $51.80 | $1,036,000.00 | |
| 8/24/2016 | John Mcmahon | VP | Sell | 137 | $51.30 | $7,028.10 | |
| 8/9/2016 | Steve Asakowicz | EVP | Sell | 4,698 | $52.55 | $246,879.90 | |
| 8/3/2016 | Kevin S Wilson | CEO | Sell | 30,736 | $47.34 | $1,455,042.24 | |
| 7/29/2016 | Kevin S Wilson | CEO | Sell | 20 | $43.95 | $879.00 | |
| 7/20/2016 | Kevin S Wilson | CEO | Sell | 3,779 | $44.02 | $166,351.58 | |
| 7/18/2016 | Kevin S Wilson | CEO | Sell | 5,465 | $44.31 | $242,154.15 | |
| 7/8/2016 | Kevin S Wilson | CEO | Sell | 10,000 | $42.37 | $423,700.00 | |
| 7/7/2016 | Jason A. Napolitano | CFO | Sell | 20,000 | $41.00 | $820,000.00 | |
| 7/6/2016 | Kevin S Wilson | CEO | Sell | 5,960 | $40.27 | $240,009.20 | |
| 7/1/2016 | Kevin S Wilson | CEO | Sell | 14,040 | $38.94 | $546,717.60 | |
| 6/2/2016 | Kevin S Wilson | CEO | Sell | 20,000 | $36.74 | $734,800.00 | |
| 5/12/2016 | Kevin S Wilson | CEO | Sell | 5,000 | $38.50 | $192,500.00 | |
| 5/10/2016 | Kevin S Wilson | CEO | Sell | 15,000 | $36.75 | $551,250.00 | |
| 5/10/2016 | Michael J Mcginley | Insider | Sell | 5,998 | $36.50 | $218,927.00 | |
| 5/10/2016 | Sharon L Riley | Director | Sell | 5,000 | $36.87 | $184,350.00 | |
| 5/9/2016 | Kevin S Wilson | CEO | Sell | 11,000 | $35.61 | $391,710.00 | |
| 5/5/2016 | Sharon L Riley | Director | Sell | 15,000 | $35.66 | $534,900.00 | |
| 5/3/2016 | Jason A Napolitano | CFO | Sell | 5,000 | $35.75 | $178,750.00 | |
| 3/8/2016 | Sharon L Riley | Director | Buy | 1,000 | $32.49 | $32,490.00 | |
| 1/27/2016 | Jason A Napolitano | CFO | Sell | 15,000 | $37.00 | $555,000.00 | |
| 12/29/2015 | Jason A. Napolitano | CFO | Sell | 3,700 | $40.03 | $148,111.00 | |
| 12/3/2015 | Kevin S Wilson | CEO | Sell | 6,000 | $35.50 | $213,000.00 | |
| 11/25/2015 | Michael J. Mcginley | insider | Sell | 958 | $33.62 | $32,207.96 | |
| 11/24/2015 | Michael J. Mcginley | insider | Sell | 1,427 | $33.33 | $47,561.91 | |
| 9/11/2015 | Jason A Napolitano | CFO | Sell | 1,699 | $33.51 | $56,933.49 | |
| 8/31/2015 | Jason A. Napolitano | CFO | Sell | 4,998 | $33.59 | $167,882.82 | |
| 8/31/2015 | Robert B. Grieve | insider | Sell | 11,098 | $33.77 | $374,779.46 | |
| 8/27/2015 | Robert B. Grieve | insider | Sell | 3,604 | $33.79 | $121,779.16 | |
| 8/17/2015 | Kevin S Wilson | CEO | Sell | 2,498 | $34.90 | $87,180.20 | |
| 8/17/2015 | Robert B Grieve | Insider | Sell | 8,033 | $34.91 | $280,432.03 | |
| 8/14/2015 | Kevin S Wilson | CEO | Sell | 2,101 | $34.90 | $73,324.90 | |
| 8/14/2015 | Rod Lippincott | EVP | Sell | 3,898 | $34.19 | $133,272.62 | |
| 7/13/2015 | Robert B Grieve | Insider | Sell | 1,000 | $29.99 | $29,990.00 | |
| 6/8/2015 | Kevin S Wilson | CEO | Sell | 11,810 | $30.08 | $355,244.80 | |
| 6/3/2015 | Robert B Grieve | Insider | Sell | 17,000 | $31.36 | $533,120.00 | |
| 6/1/2015 | Jason A Napolitano | CFO | Sell | 7,536 | $32.26 | $243,111.36 | |
| 5/22/2015 | Steven M Eyl | EVP | Sell | 5,981 | $30.19 | $180,566.39 | |
| 4/24/2015 | Robert B Grieve | Insider | Sell | 6,000 | $29.67 | $178,020.00 | |
| 4/13/2015 | Robert B Grieve | Insider | Sell | 4,000 | $26.54 | $106,160.00 | |
| 3/9/2015 | Jason A Napolitano | CFO | Sell | 5,765 | $26.02 | $150,005.30 | |
| 3/9/2015 | Kevin S Wilson | CEO | Sell | 10,000 | $25.38 | $253,800.00 | |
| 3/9/2015 | Robert B Grieve | Insider | Sell | 2,000 | $25.26 | $50,520.00 | |
| 11/30/2014 | David E Sveen | Director | Buy | 21,428 | $14.00 | $299,992.00 | |
| 11/30/2014 | Kevin S Wilson | CEO | Sell | 28,928 | $14.00 | $404,992.00 | |
| 11/21/2014 | Robert B Grieve | Insider | Sell | 6,500 | $15.25 | $99,125.00 | |
| 11/3/2014 | William A Aylesworth | Director | Sell | 5,000 | $13.67 | $68,350.00 | |
| 8/4/2014 | Robert B Grieve | Director | Sell | 12,000 | $13.57 | $162,840.00 | |
| 5/14/2014 | William Aylesworth | Director | Sell | 4,200 | $10.89 | $45,738.00 | |
| 3/31/2014 | Carol Wrenn | Director | Buy | 1,000 | $10.50 | $10,500.00 | |
| 3/31/2014 | Robert Grieve | CEO | Sell | 7,000 | $10.50 | $73,500.00 | |
| 3/1/2013 | William A Aylesworth | Director | Buy | 2,000 | $8.34 | $16,680.00 | |
| 10/3/2012 | Master Fund L.P. Cmc | Major Shareholder | Sell | 11,002 | $9.54 | $104,959.08 | |
| 8/28/2012 | William A Aylesworth | Director | Buy | 2,000 | $7.95 | $15,900.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Heska Corp (NASDAQ:HSKA)
Latest Headlines for Heska Corp (NASDAQ:HSKA)
| Source: |
|
| Date | Headline |
|---|
 | Nancy Wisnewski Sells 250 Shares of Heska Corp (HSKA) Stock
www.americanbankingnews.com - May 25 at 8:28 PM |
| Heska Corp (HSKA) CFO John Mcmahon Sells 587 Shares
www.americanbankingnews.com - May 25 at 8:26 PM |
| Heska Corp (HSKA) Director Carol Wrenn Sells 1,630 Shares
www.americanbankingnews.com - May 25 at 8:05 PM |
| Heska Corp (HSKA) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - May 15 at 12:47 PM |
| $33.63 Million in Sales Expected for Heska Corp (HSKA) This Quarter
www.americanbankingnews.com - May 10 at 8:54 AM |
| Heska Corp (HSKA) Expected to Announce Earnings of $0.37 Per Share
www.americanbankingnews.com - May 9 at 12:23 AM |
| Heska Corp (HSKA) Rating Reiterated by B. Riley
www.americanbankingnews.com - May 8 at 6:39 PM |
| Sharon J. Larson Buys 1,000 Shares of Heska Corp (HSKA) Stock
www.americanbankingnews.com - May 5 at 1:51 PM |
| FY2017 Earnings Estimate for Heska Corp (HSKA) Issued By Gabelli
www.americanbankingnews.com - May 5 at 1:38 PM |
| Q3 2017 EPS Estimates for Heska Corp Reduced by B. Riley (HSKA)
www.americanbankingnews.com - May 5 at 11:18 AM |
| Heska Corp (HSKA) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - May 5 at 12:04 AM |
| FY2019 Earnings Forecast for Heska Corp (HSKA) Issued By Gabelli
www.americanbankingnews.com - May 4 at 8:02 PM |
 | Heska Corp. – Value Analysis (NASDAQ:HSKA) : May 4, 2017
finance.yahoo.com - May 4 at 5:55 PM |
| Q2 2017 EPS Estimates for Heska Corp Increased by B. Riley (HSKA)
www.americanbankingnews.com - May 4 at 12:38 PM |
| Somewhat Favorable Press Coverage Likely to Impact Heska Corp (HSKA) Share Price
www.americanbankingnews.com - May 4 at 12:52 AM |
| Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : May 3, 2017
finance.yahoo.com - May 3 at 4:47 PM |
| Edited Transcript of HSKA earnings conference call or presentation 2-May-17 3:00pm GMT
finance.yahoo.com - May 3 at 4:47 PM |
| Heska Corp (HSKA) Announces Earnings Results, Beats Estimates By $0.31 EPS
www.americanbankingnews.com - May 2 at 4:32 PM |
 | Heska's (HSKA) CEO Kevin Wilson on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 2 at 4:14 PM |
| Here's Why Heska Corporation Is Dropping Today
finance.yahoo.com - May 2 at 4:14 PM |
 | Here's Why Heska Corporation Is Dropping Today
www.fool.com - May 2 at 12:55 PM |
| Heska Reports First Quarter Results
finance.yahoo.com - May 2 at 10:11 AM |
| Investor Network: Heska Corporation to Host Earnings Call
finance.yahoo.com - May 2 at 10:11 AM |
| Heska posts 1Q profit
finance.yahoo.com - May 2 at 10:11 AM |
| Heska Corp (HSKA) Earning Positive Media Coverage, Report Shows
www.americanbankingnews.com - April 30 at 12:47 PM |
| Heska Corp's (HSKA) "Neutral" Rating Reaffirmed at B. Riley
www.americanbankingnews.com - April 28 at 7:34 AM |
| Somewhat Positive Press Coverage Somewhat Likely to Impact Heska Corp (HSKA) Share Price
www.americanbankingnews.com - April 28 at 1:01 AM |
| Heska To Present at Four Upcoming Conferences
finance.yahoo.com - April 27 at 8:26 AM |
| Reminder: Heska Annual Meeting of Stockholders on May 1, 2017
finance.yahoo.com - April 26 at 7:36 PM |
| Somewhat Favorable News Coverage Likely to Affect Heska Corp (HSKA) Stock Price
www.americanbankingnews.com - April 22 at 11:59 AM |
| Short Interest in Heska Corp (HSKA) Expands By 45.2%
www.americanbankingnews.com - April 21 at 11:01 AM |
| Heska Corp (HSKA) Expected to Announce Quarterly Sales of $31.81 Million
www.americanbankingnews.com - April 20 at 3:23 PM |
| Zacks.com featured highlights: Heska, Zeltiq Aesthetics, YY, MaxLinear and Teradyne
finance.yahoo.com - April 20 at 11:42 AM |
| Heska Corp (HSKA) Getting Somewhat Negative Press Coverage, Report Shows
www.americanbankingnews.com - April 19 at 12:11 PM |
| Heska Corp (HSKA) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - April 18 at 1:50 PM |
 | Roche's Hemophilia A Drug Positive in Second Phase III Study
www.msn.com - April 18 at 11:12 AM |
| Bristol-Myers and Nordic Ink Biomarker Collaboration Deal
finance.yahoo.com - April 18 at 11:12 AM |
| $0.24 Earnings Per Share Expected for Heska Corp (HSKA) This Quarter
www.americanbankingnews.com - April 18 at 9:11 AM |
| Biogen to License Alzheimer Candidate from Bristol-Myers
www.msn.com - April 17 at 11:01 AM |
| Neurocrine's Stock Up, FDA Nod for Tardive Dyskinesia Drug
finance.yahoo.com - April 14 at 9:21 AM |
| Heska Schedules First Quarter 2017 Financial Results Conference Call for May 2, 2017
finance.yahoo.com - April 13 at 10:26 AM |
| Jason A. Napolitano Sells 1,100 Shares of Heska Corp (HSKA) Stock
www.americanbankingnews.com - April 12 at 4:47 PM |
| Jason A. Napolitano Sells 3,900 Shares of Heska Corp (HSKA) Stock
www.americanbankingnews.com - April 12 at 4:47 PM |
| Heska Schedules Annual Meeting of Stockholders for May 1, 2017
finance.yahoo.com - April 12 at 9:19 AM |
| Roche Announces Positive Data on Lung Cancer Drug Alecensa
finance.yahoo.com - April 7 at 10:18 AM |
 | Heska Corp. (HSKA) Climbed To A New High After S&P Makes Changes
www.rttnews.com - March 31 at 5:46 PM |
 | Heska Corp. (HSKA) Has Climbed To A New High After S&P Makes Index Changes
www.nasdaq.com - March 30 at 6:08 PM |
 | Regeneron & Sanofi's Atopic Dermatitis Drug Gets FDA Nod
us.rd.yahoo.com - March 29 at 6:17 PM |
| Why Heska Corporation (HSKA) Could Be an Impressive Growth Stock
finance.yahoo.com - March 27 at 11:12 AM |
| Heska Corp (HSKA) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - March 24 at 2:23 PM |
Heska Corp (HSKA) Chart for Friday, May, 26, 2017
